IL17A and type 2 diabetes mellitus: IL17, as a pathogenic factor in diabetes, was evidenced by Dr. Ohshima, who showed that anti-IL17 antibodies significantly improved glucose tolerance in KK-Ay mice (spontaneous and polygenic T2D model, resembling human T2D features) [145].